The State Council's inter-agency task force held a press conference in Beijing on Thursday on China's COVID-19 vaccine.
China SCIO丨Updated: December 31, 2020
×
Wu Yonglin, president of the China National Biotech Group, a subsidiary of the China National Pharmaceutical Group (Sinopharm), attends the press conference in Beijing on Dec. 31, 2020. [Photo by Xu Xiang/China SCIO]